Bristol-Myers Squibb Co (LTS:0R1F)
$ 59.4 -0.61 (-1.02%) Market Cap: 119.70 Bil Enterprise Value: 163.01 Bil PE Ratio: 0 PB Ratio: 6.98 GF Score: 82/100

Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: $72.72 (+1.07%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Chris Schott at JPMorgan, and it's great to see everyone back in person again at the conference. It's my pleasure today to be introducing Bristol-Myers Squibb to again kick off the JPMorgan conference. From the company, we have Chris Boerner, the Chief Commercial Officer. And unfortunately, Giovanni was unable to be with us today as he is recovering from COVID.

Before I turn it over to Chris, I did want to remind people that we've moved away from the breakout session format this year at the conference. So we're going to be doing Q&A from the stage after the presentation. And if anybody has any questions, you can use the app to send those to me, and I'll work them into the conversation. So with that, Chris, Happy New Year, thanks for joining us and look forward to the presentation.

Christopher S. Boerner
Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer

Thank you, Chris.

So good morning,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot